Cryo Cell International Inc financial data

Symbol
CCEL on NYSE
Industry
Services-Misc Health & Allied Services, NEC
Location
700 Brooker Creek Blvd, Suite 1800, Oldsmar, FL
State of incorporation
DE
Fiscal year end
November 30
Latest financial report
10-Q - Q1 2025 - Apr 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 57.2 % +14.7%
Quick Ratio 3.53 % -20.2%
Debt-to-equity -628 % +50.7%
Return On Equity -1.07 % -101%
Return On Assets 0.2 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.08M shares -0.28%
Common Stock, Shares, Outstanding 8.08M shares -2.09%
Entity Public Float 43.8M USD +62.3%
Common Stock, Value, Issued 149K USD +0.14%
Weighted Average Number of Shares Outstanding, Basic 8.08M shares -2.36%
Weighted Average Number of Shares Outstanding, Diluted 8.2M shares -1.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 838K USD -47.5%
Costs and Expenses 28.4M USD -36.3%
Operating Income (Loss) 3.72M USD +28.6%
Nonoperating Income (Expense) -1.17M USD -89.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.54M USD -32.8%
Income Tax Expense (Benefit) 2.41M USD +5.29%
Net Income (Loss) Attributable to Parent 129K USD -49.1%
Earnings Per Share, Basic 0.01 USD/shares -57.1%
Earnings Per Share, Diluted 0.01 USD/shares -57.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 223K USD -9.71%
Marketable Securities, Current 3.26M USD +345%
Accounts Receivable, after Allowance for Credit Loss, Current 7.21M USD +7.21%
Inventory, Net 730K USD -3.27%
Other Assets, Current 436K USD +15.3%
Assets, Current 12.5M USD +32.3%
Deferred Income Tax Assets, Net 20.8M USD +1.51%
Property, Plant and Equipment, Net 21.7M USD +0.56%
Operating Lease, Right-of-Use Asset 714K USD -25.4%
Intangible Assets, Net (Excluding Goodwill) 904K USD -6.98%
Goodwill 1.94M USD 0%
Other Assets, Noncurrent 30.1M USD -1.65%
Assets 64.4M USD +4.33%
Accounts Payable, Current 2.74M USD -8.42%
Accrued Liabilities, Current 4.34M USD +10.7%
Contract with Customer, Liability, Current 9.44M USD +0.48%
Liabilities, Current 21.7M USD +12.1%
Contract with Customer, Liability, Noncurrent 47.7M USD +12%
Operating Lease, Liability, Noncurrent 387K USD -49.7%
Other Liabilities, Noncurrent 57.3M USD +8.8%
Liabilities 79M USD +9.7%
Retained Earnings (Accumulated Deficit) -34.5M USD -12.8%
Stockholders' Equity Attributable to Parent -14.7M USD -41.8%
Liabilities and Equity 64.4M USD +4.33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 954K USD
Net Cash Provided by (Used in) Financing Activities -1M USD -286%
Net Cash Provided by (Used in) Investing Activities -287K USD +15.7%
Common Stock, Shares Authorized 20M shares 0%
Common Stock, Shares, Issued 14.9M shares +0.14%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 485K USD +9.37%
Deferred Tax Assets, Valuation Allowance 1.5M USD -0.79%
Deferred Tax Assets, Gross 23.7M USD +0.67%
Operating Lease, Liability 839K USD -18%
Payments to Acquire Property, Plant, and Equipment 62.1K USD -86.4%
Property, Plant and Equipment, Gross 27.5M USD -5.47%
Operating Lease, Liability, Current 452K USD +78%
Lessee, Operating Lease, Liability, to be Paid, Year Two 38.2K USD -91.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 491K USD +12.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 67.3K USD -51.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 38.2K USD -91.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 500K shares 0%
Unrecognized Tax Benefits 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four 38.2K USD
Operating Lease, Payments 392K USD +18.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 68K USD -23.6%
Depreciation, Depletion and Amortization 248K USD +188%
Share-based Payment Arrangement, Expense 771K USD -4.93%
Interest Expense 2.1M USD +105%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%